Ergoteles LLC Ab Cellera Biologics Inc. Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$5.66 - $7.59 $2.17 Million - $2.91 Million	383,854 Added 1095.22%	418,902 $2.71 Million
Q1 2023 May 10, 2023	BUY	$7.31 - $11.18 $256,200 - $391,836	35,048 New	35,048 $264,000
Q4 2021 Feb 14, 2022	SELL	$12.99 - $17.73 $4.31 Million - $5.88 Million	-331,414 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$14.85 - $21.34 $2.2 Million - $3.16 Million	148,078 Added 80.77%	331,414 $6.64 Million
Q2 2021 Aug 12, 2021	BUY	$20.19 - $34.17 $3.7 Million - $6.26 Million	183,336 New	183,336 $4.03 Million

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.